
Robert D. Broderick, MD
Ophthalmology in Manhasset, NY
- Enrolled in Medicare
- 49 years since graduation
- Public record — not managed by the clinician
About Dr. Robert Broderick
Dr. Robert Broderick is a physician specializing in ophthalmology practicing in Manhasset, NY, a graduate of New York Medical College (1977). Treated 909 Medicare patients in 2024.
- Ophthalmology
- Enrolled in Medicare
- In-person visits at the practice
Provider details
| Specialty | OphthalmologyOther ophthalmology doctors in Manhasset |
|---|---|
| Also practices | General Surgery |
| Credentials | MD |
| Education | New York Medical College, 1977CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1275537656National Provider Identifier (CMS NPPES), issued June 2005 |
| Medicare | Enrolled in MedicareCMS Doctors and Clinicians |
Dr. Robert Broderick's specialties and state licenses
- Ophthalmology Primary
License: NY 141375
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Where Dr. Robert Broderick practices
-
Practice address 1355 Northern Blvd, Suite 300, Manhasset, NY 11030 Directions
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Robert Broderick's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient complete exam of visual system | 714 | $145.92 |
| Established patient problem focused exam of visual system | 182 | $103.40 |
| Imaging of retina | 149 | $47.01 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 115 | $105.05 |
| Imaging of optic nerve | 68 | $42.69 |
| New patient complete exam of visual system | 67 | $169.69 |
| Exam of visual field with extended testing | 23 | $74.73 |
| Removal of eyelashes using forceps | 22 | $21.57 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Dr. Robert Broderick (2025)
$258.49 in 10 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 10 | $258.49 |
Paying companies: Harrow Eye, LLC ($74.04), Thea Pharma Inc. ($44.48), Dompe US, Inc. ($32.87), Oyster Point Pharma, Inc. ($31.67), ANI Pharmaceuticals, Inc. ($31.47), Tarsus Pharmaceuticals, Inc. ($22.84).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Robert Broderick
What kind of clinician is Dr. Robert Broderick?
Dr. Robert Broderick is listed as a physician specializing in ophthalmology, also practicing general surgery.
Where does Dr. Robert Broderick practice?
The main practice address at 1355 Northern Blvd, Suite 300, Manhasset, NY 11030.
What is the NPI number of Dr. Robert Broderick?
The National Provider Identifier is 1275537656.
Does Dr. Robert Broderick accept Medicare?
CMS lists this clinician as enrolled in Medicare. Ask the office about assignment and your plan.
Where did Dr. Robert Broderick go to medical school?
New York Medical College, graduating in 1977.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2019-09-09 |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.